- Home
- KMDA vs EVN Comparison
KMDA vs EVN Comparison
Compare KMDA & EVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- EVN
- Stock Information
- Founded
- KMDA 1990
- EVN 1998
- Country
- KMDA Israel
- EVN United States
- Employees
- KMDA N/A
- EVN N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- EVN Investment Bankers/Brokers/Service
- Sector
- KMDA Health Care
- EVN Finance
- Exchange
- KMDA Nasdaq
- EVN Nasdaq
- Market Cap
- KMDA 426.0M
- EVN 418.1M
- IPO Year
- KMDA N/A
- EVN N/A
- Fundamental
- Price
- KMDA $6.71
- EVN $10.34
- Analyst Decision
- KMDA Strong Buy
- EVN
- Analyst Count
- KMDA 3
- EVN 0
- Target Price
- KMDA $14.67
- EVN N/A
- AVG Volume (30 Days)
- KMDA 143.8K
- EVN 101.2K
- Earning Date
- KMDA 03-05-2025
- EVN 01-01-0001
- Dividend Yield
- KMDA 2.95%
- EVN 4.78%
- EPS Growth
- KMDA 66.67
- EVN N/A
- EPS
- KMDA 0.25
- EVN 0.34
- Revenue
- KMDA $160,953,000.00
- EVN N/A
- Revenue This Year
- KMDA $11.45
- EVN N/A
- Revenue Next Year
- KMDA $9.94
- EVN N/A
- P/E Ratio
- KMDA $26.22
- EVN $29.94
- Revenue Growth
- KMDA 12.93
- EVN N/A
- 52 Week Low
- KMDA $4.74
- EVN $8.64
- 52 Week High
- KMDA $9.15
- EVN $10.45
- Technical
- Relative Strength Index (RSI)
- KMDA 44.68
- EVN 43.98
- Support Level
- KMDA $6.44
- EVN $10.18
- Resistance Level
- KMDA $7.17
- EVN $10.37
- Average True Range (ATR)
- KMDA 0.20
- EVN 0.14
- MACD
- KMDA -0.02
- EVN -0.02
- Stochastic Oscillator
- KMDA 37.36
- EVN 29.41
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.